The story that has been circulating online today tells of how a tech entrepreneur decided to help his dog using modern technologies. Rosie, his pet, was diagnosed with aggressive cancer — and standard treatments proved ineffective: the tumors continued to grow. Then, Paul Coningham decided to try something new and turned to artificial intelligence.
He started by sending DNA samples of Rosie to a specialized genomics center to obtain complete data on her genetic code. He used this information to analyze it with various AI tools to identify mutations causing the cancer. The detected anomalies were then fed into the AlphaEvolve system, which studied proteins and identified potential therapeutic targets.
Next, all the results were sent to the RNA Institute at the University of New South Wales (UNSW), where scientists used them to create a personalized mRNA vaccine — specifically tailored to this dog’s genetic profile. In late 2025, Rosie received a series of injections, and already one of the largest tumors has shrunk by about half. Additionally, her overall well-being has noticeably improved.
This was the first case in the world where an individualized mRNA vaccine against cancer was developed for an animal. In the future, a second version of the treatment is planned for Rosie to combat remaining tumors — also with the help of artificial intelligence.
Sometimes, it happens: when the right tool is in the hands of those who know how to use it properly.
Created with n8n:
https://cutt.ly/n8n
Created with syllaby:
https://cutt.ly/syllaby